Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/20616
Title: Neoadjuvant as Future for Drug Development in Breast Cancer-Letter
Authors: BUYSE, Marc 
BURZYKOWSKI, Tomasz 
Saad, Everardo D.
Issue Date: 2016
Publisher: AMER ASSOC CANCER RESEARCH
Source: CLINICAL CANCER RESEARCH, 22 (1), p. 268-268
Notes: [Buyse, Marc] Int Inst Drug Dev, San Francisco, CA USA. [Buyse, Marc; Burzykowski, Tomasz] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BioSt, Hasselt, Belgium. [Burzykowski, Tomasz; Saad, Everardo D.] Int Inst Drug Dev, Louvain La Neuve, Belgium. [Saad, Everardo D.] Dendrix Res, Sao Paulo, Brazil.
Document URI: http://hdl.handle.net/1942/20616
ISSN: 1078-0432
e-ISSN: 1557-3265
DOI: 10.1158/1078-0432.CCR-15-1047
ISI #: 000367550300030
Category: A1
Type: Journal Contribution
Validations: ecoom 2017
Appears in Collections:Research publications

Show full item record

SCOPUSTM   
Citations

4
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

4
checked on Apr 22, 2024

Page view(s)

64
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.